Aldeyra Therapeutics Inc
F:137
Aldeyra Therapeutics Inc
F:137
Price:
1.33
EUR
0.76%
Market Closed
Market Cap:
€77m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aldeyra Therapeutics Inc
F:137
|
US |
|
Univest Financial Corp
F:UVE
|
US |
|
Nanobiotix SA
F:5NRA
|
FR |
|
S
|
SGL Carbon SE
XMUN:SGL
|
DE |
|
Agora Inc
NASDAQ:API
|
CN |
|
Mizuho Leasing Co Ltd
F:LFB
|
JP |
|
OPKO Health Inc
NASDAQ:OPK
|
US |
|
M
|
Micro Leasing PCL
SET:MICRO
|
TH |
|
F
|
First Phosphate Corp
CNSX:PHOS
|
CA |
|
Caleres Inc
NYSE:CAL
|
US |
|
A
|
Allied Circuit Co Ltd
TPEX:8155
|
TW |
Wall St Price Targets
Price Targets Summary
Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc
Wall Street analysts forecast Aldeyra Therapeutics Inc stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for Aldeyra Therapeutics Inc is 5.95 EUR with a low forecast of 1.73 EUR and a high forecast of 11.71 EUR.
Lowest Forecast
Price Target
1.73
EUR
30% Upside
Average Forecast
Price Target
5.95
EUR
347% Upside
Highest Forecast
Price Target
11.71
EUR
781% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Aldeyra Therapeutics Inc's stock price target?
Price Target
5.95
EUR
5.95
EUR
According to Wall Street analysts, the average 1-year price target for Aldeyra Therapeutics Inc is 5.95 EUR with a low forecast of 1.73 EUR and a high forecast of 11.71 EUR.
